Table 3: Overall survival according to demographic and clinical characteristic stratified against treatment modalities (n = 124).
Covariates |
ACT |
NACT |
||||
n = 93 |
OS (83.9%) |
p-value |
n = 31 |
OS (48.4%) |
p-value |
|
Age < 50 years ≥ 50 years |
31 62 |
96.8 77.4 |
0.013 |
14 17 |
57.1 41.2 |
0.562 |
Ethnic Malay Non-Malay |
54 39 |
87.0 79.5 |
0.353 |
24 7 |
45.8 57.1 |
0.621 |
Stage Early stage Advanced stage |
39 54 |
94.9 75.9 |
0.022
|
5 26 |
100.0 38.5 |
0.085 |
Molecular subtypes Luminal A TNBC Other |
36 13 44 |
86.1 84.6 81.8 |
0.445 |
6 5 20 |
80.0 40.0 50.0 |
0.701 |
Chemotherapy Anthracycline based Taxane based Anthracycline+Taxane |
57 3 33 |
80.7 33.3 93.9 |
0.002
1-2* 2-3** |
23 3 5 |
56.5 33.3 60.0 |
0.184 |
Schedule modification No Modification With Modification |
41 52 |
92.7 76.9 |
0.058 |
13 18 |
46.2 50.0 |
0.883 |
*p < 0.05 , **p < 0.005